CD8A and neoplasm: The synergistic anti-tumor effect of TP-0903 and WIN55-212 in vivo was attributed to the promotion of apoptotic cells and reduction in microvessel density in tumor tissue, but also to an increase in CD8+ cytotoxic T cells infiltrating into the tumor microenvironment.